Hence, blunted nucleotide biosynthesis, together with epigenetic silencing of potent growth and multipotency factors in response to IDH3α loss of function, creates a unique metabolic vulnerability in highly proliferative GBM cells, that decreases cellular viability. Here, IDH3A is linked to glioblastoma.